Mayne Pharma reports unaudited 3Q FY26 results
Filed with ASX · · 5 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings CallMayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- S&P DJI Announces March 2026 Quarterly Rebalance
- Mayne Pharma management changes
- 2026 Half Year Investor Presentation
- 2026 Half Year Media Release
- Half Yearly Report and Accounts
Later from Mayne Pharma
- Court awards MYX $13.27m for legal costs from Cosette
- Mayne Pharma receives $14.4m for legal costs from Cosette
- Mayne Pharma reports unaudited Q4 and FY26 results
- Mayne Pharma to present at the 20th Bioshares Summit
- Non-Executive Director appointment
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma